Stress link to breast cancer ?
WOMEN with high levels of stress in their everyday lives are at less risk than others of developing breast cancer for the first time, according to research.
Scientists from Denmark drew their conclusions after studying 6,689 women for 18 years, and speculated that it may be because daily stress suppressed production of oestrogen, which is a risk factor in breast cancer.
"Prolonged low key stress of everyday life results in a persistent activation of stress hormones which may impair oestrogen synthesis and may therefore be related to lower risk of breast cancer," they wrote.
However, they pointed out that this theory was untested and deserved greater investigation. But they warned that stress was not a health cure, since high levels had also been linked to higher risk of heart disease.
About the Author
www.medical-explorer.com
Written by:
Anonymous
|
Updates and Recent News
Estrogen Alone HRT Does Not Increase Breast Cancer Risk
New research is suggesting that estrogen may not be as bad it was thought in terms of breast cancer risk. Scientists have found that estrogen-alone hormone treatment does not increase the risk of breast cancer in postmenopausal women. This result comes from an updated analysis of the Women's Health Initiative (WHI) Estrogen-Alone Trial....
To Read More...
Higher Placental Weight Higher The Breast Cancer Risk
Women with a higher placental weight in prior pregnancies have an increased risk of breast cancer, possibly from the hormones produced by the placenta, according to a study in the November 16 issue of JAMA. ..
To Read More...
Chemotherapy Drug Can Cause Fatal Reaction
CHICAGO -- Cremophor-containing paclitaxel, a drug used in treating cancer, has been associated with allergic reactions, some fatal, U.S. researchers said. Researchers at Northwestern University Feinberg School of Medicine identified 287 unique cases of hypersensitivity reactions submitted to the FDA's Adverse Event Report System from 1997-2007, with 109 deaths in patients who received Cremophor-based paclitaxel, a solvent-administered taxane chemotherapy. Adverse event reports generally only represent from 1 percent to 10 percent of actual incidence, so the number of hypersensitivity reactions and deaths is likely significantly higher, the researchers said. Study leader Dr. Charles Bennett of Northwestern's Feinberg.
To Read More...
|
